Opportunity Information: Apply for PAR 23 252

The Alcohol Health Services Research (R34 Clinical Trial Optional) funding opportunity (PAR 23-252) is a National Institutes of Health grant sponsored by the National Institute on Alcohol Abuse and Alcoholism (NIAAA). It supports early-stage, time-limited projects in alcohol health services research, with the broader goal of closing the treatment gap for people with alcohol use disorder (AUD). In practical terms, the program is looking for studies that can move the field toward more people with AUD getting effective care, staying engaged in that care, and receiving services that are feasible in real-world settings. The "clinical trial optional" label means applicants may propose studies that include clinical trials when appropriate, but a clinical trial is not required if the research aims can be met through other rigorous designs.

The NOFO highlights five main research emphasis areas tied directly to reducing the AUD treatment gap. First, it prioritizes approaches that increase access to AUD treatment, which can include removing structural barriers, expanding where and how services are delivered, and improving pathways into care. Second, it encourages work that makes treatment more appealing, recognizing that stigma, inconvenience, negative past experiences, and misalignment with patient preferences can reduce treatment uptake and retention. Third, it calls for research that examines cost structures and insurance systems, reflecting the reality that financing, reimbursement, and benefit design often shape what services are available and whether patients can afford them. Fourth, it supports dissemination and implementation studies focused on existing evidence-based AUD interventions, with an emphasis on understanding how to scale what already works across different care settings (rather than inventing entirely new treatments). Fifth, it elevates reducing health disparities as an explicit strategy for closing the treatment gap, focusing attention on improving reach and outcomes for health disparity populations who may face compounded barriers to accessing high-quality AUD care.

Eligibility for this grant is broad and spans many organization types that could realistically conduct health services research or partner with delivery systems and communities. Eligible applicants include state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; Native American tribal organizations that are not federally recognized; public housing authorities and Indian housing authorities; and both nonprofit organizations (with or without 501(c)(3) status) and for-profit organizations (other than small businesses), as well as small businesses. The NOFO also explicitly names additional eligible applicant categories such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribal Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISISs). Faith-based and community-based organizations are included, and the announcement allows eligible federal agencies, regional organizations, U.S. territories or possessions, and even non-U.S. entities (foreign organizations), which underscores an interest in diverse settings, populations, and delivery systems.

From an administrative standpoint, this is a discretionary grant in the health funding category, listed under CFDA 93.273. The opportunity shows an award ceiling of $450,000, indicating the maximum amount expected per award under this announcement. The posted original closing date is 2026-09-07, and the opportunity was created on 2023-08-09. Overall, the grant is designed for teams aiming to generate the groundwork and evidence needed to improve how AUD services are delivered, paid for, implemented, and equitably accessed, with a clear emphasis on practical impact in health systems and communities.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Alcohol Health Services Research (R34 Clinical Trial Optional)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.273.
  • This funding opportunity was created on 2023-08-09.
  • Applicants must submit their applications by 2026-09-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $450,000.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PAR 23 252

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Frequently Asked Questions (FAQs)

What is the Alcohol Health Services Research (R34 Clinical Trial Optional) opportunity?

It is a National Institutes of Health (NIH) funding opportunity titled "Alcohol Health Services Research (R34 Clinical Trial Optional)" (PAR 23-252), sponsored by the National Institute on Alcohol Abuse and Alcoholism (NIAAA). It supports early-stage, time-limited projects in alcohol health services research.

What is the main purpose of this grant?

The program is aimed at helping close the treatment gap for people with alcohol use disorder (AUD). The focus is on research that can move real-world systems toward getting more people into effective AUD care, keeping them engaged, and making services feasible in typical community and health system settings.

What does "health services research" mean in the context of this opportunity?

Based on the emphasis areas listed in the announcement, this refers to research about how AUD services are accessed, delivered, paid for, implemented, and scaled in real-world settings, including the systems and structures that influence whether people can receive and stay in care.

What does "R34" indicate about the type of project?

The R34 mechanism is described here as supporting early-stage, time-limited projects. In practical terms, this opportunity is designed to generate groundwork and evidence that can improve how AUD-related services operate in health systems and communities.

Is a clinical trial required?

No. The funding opportunity is labeled "clinical trial optional," meaning applicants may propose studies that include clinical trials when appropriate, but a clinical trial is not required if the research aims can be met through other rigorous study designs.

What kinds of research topics are prioritized?

The announcement highlights five main emphasis areas tied to reducing the AUD treatment gap: (1) increasing access to AUD treatment; (2) making treatment more appealing to patients; (3) examining cost structures and insurance systems; (4) dissemination and implementation studies that scale existing evidence-based AUD interventions; and (5) reducing health disparities as a direct strategy to close the treatment gap.

What does the grant mean by increasing access to AUD treatment?

It prioritizes approaches that remove structural barriers, expand where and how services are delivered, and improve pathways into care so more people with AUD can start treatment.

What does "making treatment more appealing" involve?

The opportunity recognizes that people may avoid or leave treatment due to stigma, inconvenience, negative past experiences, or a mismatch with patient preferences. Research that addresses these factors to improve uptake and retention aligns with this emphasis.

How do cost structures and insurance systems fit into the research goals?

The NOFO explicitly calls for research examining financing, reimbursement, and benefit design, since these factors often determine which AUD services exist in practice and whether patients can afford them.

Does this opportunity support creating brand-new AUD treatments?

The dissemination and implementation emphasis is described as focusing on existing evidence-based AUD interventions, with an emphasis on understanding how to scale what already works across different care settings rather than inventing entirely new treatments.

What types of dissemination and implementation work are encouraged?

Studies are encouraged that look at how to implement and scale evidence-based AUD interventions across different care settings, with attention to real-world feasibility and broader reach.

How is reducing health disparities addressed in this opportunity?

Reducing health disparities is elevated as an explicit strategy for closing the AUD treatment gap, with attention to improving reach and outcomes for health disparity populations who may face compounded barriers to high-quality AUD care.

Who is eligible to apply?

Eligibility is broad and includes many organization types that can conduct health services research or partner with delivery systems and communities, including governments, higher education institutions, tribal entities, nonprofits, for-profits, small businesses, and additional named categories of institutions.

Which government entities are eligible?

Eligible applicants include state, county, and city or township governments, as well as special district governments.

Are schools and universities eligible?

Yes. Eligible applicants include independent school districts and both public and state-controlled institutions of higher education and private institutions of higher education.

Are tribal governments and tribal organizations eligible?

Yes. Federally recognized Native American tribal governments are eligible, and Native American tribal organizations that are not federally recognized are also listed as eligible.

Are housing authorities eligible?

Yes. Public housing authorities and Indian housing authorities are listed as eligible applicants.

Can nonprofits apply even if they do not have 501(c)(3) status?

Yes. The opportunity includes nonprofit organizations with or without 501(c)(3) status.

Are for-profit organizations eligible?

Yes. For-profit organizations (other than small businesses) are eligible, and small businesses are also eligible.

Are faith-based and community-based organizations eligible?

Yes. Faith-based and community-based organizations are explicitly included among eligible applicants.

Are specific institution types like HBCUs and HSIs eligible?

Yes. The announcement explicitly names additional eligible applicant categories such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribal Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISISs).

Can federal agencies apply?

Yes. The announcement allows eligible federal agencies.

Are U.S. territories or possessions eligible?

Yes. Regional organizations and U.S. territories or possessions are included in the eligibility language provided.

Can non-U.S. organizations apply?

Yes. The eligibility list includes non-U.S. entities (foreign organizations), indicating the program is open to research in diverse settings and systems.

What is the maximum award amount listed for this opportunity?

The opportunity lists an award ceiling of $450,000, indicating the maximum amount expected per award under this announcement.

What is the CFDA number for this opportunity?

The opportunity is listed under CFDA 93.273.

What funding category and grant type is this?

It is described as a discretionary grant in the health funding category.

What is the closing date for this opportunity?

The posted original closing date is 2026-09-07.

When was the opportunity created?

The opportunity was created on 2023-08-09.

What kind of impact is NIAAA looking for from funded projects?

The announcement emphasizes practical impact: improving how AUD services are delivered, paid for, implemented, and equitably accessed, with the broader goal of increasing engagement in effective care in real-world health systems and communities.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Device Based Treatments for Substance Use Disorders (UG3/UH3 Clinical Trial Optional)

Previous opportunity: Network of Genomics-Enabled Learning Health Systems (gLHS) Coordinating Center (U01 Clinical Trials Required)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 23 252

 

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 23 252) also looked into and applied for these:

Funding Opportunity
Alcohol Health Services Research (R01 Clinical Trial Optional) Apply for PAR 23 251

Funding Number: PAR 23 251
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Elucidating Variability of Physiologic and Functional Responses to Exercise Training in Older Adults (R01 Clinical Trial Required) Apply for RFA AG 24 045

Funding Number: RFA AG 24 045
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,000,000
Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required) Apply for PAR 23 250

Funding Number: PAR 23 250
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required) Apply for PAR 23 249

Funding Number: PAR 23 249
Agency: National Institutes of Health
Category: Health
Funding Amount: $450,000
Community-Engaged Health Equity Research in Neuroscience Initiative (R01 CT Not Allowed) Apply for RFA NS 24 006

Funding Number: RFA NS 24 006
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Behavioral and Social Research on the Role of Immigration on Life Course Health and Aging, including AD/ADRD?(R01 Clinical Trial Not Allowed) Apply for RFA AG 24 028

Funding Number: RFA AG 24 028
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Behavioral and Social Research on the Role of Immigration on Life Course Health and Aging, including AD/ADRD?(R21 Clinical Trial Not Allowed) Apply for RFA AG 24 029

Funding Number: RFA AG 24 029
Agency: National Institutes of Health
Category: Health
Funding Amount: $275,000
Community-Engaged Health Equity Research in Neuroscience Initiative (R34 CT Not Allowed) Apply for RFA NS 24 007

Funding Number: RFA NS 24 007
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Neural and Non-Neural Mechanisms Underlying Gait as a Preclinical Marker for Alzheimers Disease and Alzheimers Disease-Related Dementias (R01 Clinical Trial Optional) Apply for RFA AG 24 041

Funding Number: RFA AG 24 041
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R43/R44 Clinical Trial Optional) Apply for RFA AG 24 042

Funding Number: RFA AG 24 042
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Planning for Product Development Strategy (R34 Clinical Trial Not Allowed) Apply for PAR 24 029

Funding Number: PAR 24 029
Agency: National Institutes of Health
Category: Health
Funding Amount: $225,000
USAID Improved Maternal, Newborn, Child Health, Immunization and Nutrition Activity Apply for 72065623APS00001

Funding Number: 72065623APS00001
Agency: Mozambique USAID-Maputo
Category: Health
Funding Amount: $92,000,000
Analytical and Clinical Validation of Biomarkers for Alzheimers Disease (AD) and AD-Related Dementias (ADRD)?(U01 Clinical Trial Optional) Apply for PAR 23 258

Funding Number: PAR 23 258
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R41/R42 Clinical Trial Optional) Apply for RFA AG 24 043

Funding Number: RFA AG 24 043
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
VCID Center Without Walls for Understanding and Leveraging Small Vessel Cerebrovascular Disease Mechanisms in ADRD (R01 - Clinical Trial Not Allowed) Apply for RFA NS 24 027

Funding Number: RFA NS 24 027
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,000,000
NINDS Clinical Trial Methods in Clinical Neurological Disorders Course (R25 Clinical Trial Not Allowed) Apply for RFA NS 23 030

Funding Number: RFA NS 23 030
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
AHRQ Improving Diagnostic Safety in Ambulatory Care: Strategies and Interventions (R18) Apply for PA 23 290

Funding Number: PA 23 290
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: $500,000
AHRQ Understanding and Improving Diagnostic Safety in Ambulatory Care: Incidence and Contributing Factors (R01) Apply for PA 23 291

Funding Number: PA 23 291
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: $500,000
Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required) Apply for PAR 23 274

Funding Number: PAR 23 274
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Chimeric Antigen Receptor (CAR) Approaches to AD/ADRD (R61/R33 Clinical Trial Not Allowed) Apply for RFA AG 24 046

Funding Number: RFA AG 24 046
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 23 252", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: